The global interventional cardiology market is projected to expand at a compound annual growth rate (cagr) of 7.0% over 2018–2023, generating usd 23.39 bn in revenue by 2023 and top key players are medtronic plc,boston scientific corporation ,abbott lab

Interventional cardiology is the catheter-based treatment of cardiovascular diseases (CVDs). Certified cardiologists who perform these procedures are known as intervention cardiologists. Interventional procedures are specialized examinations designed for the diagnosis or treatment of diseases. It uses minimally invasive technique, performed under the guidance of images, for treating maladies. Interventional procedures in cardiology are carried out using cardiac monitoring and medical devices. According to Netscribes, the global interventional cardiology market is projected to expand at a compound annual growth rate (CAGR) of 7.0% over 2018–2023, generating USD 23.39 Bn in revenue by 2023.

The global interventional cardiology market can be segmented based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.) and based on end user (hospital, catheterization labs, and ambulatory surgical centers).

Type segment insights:

The plaque modification devices market is expected to grow the fastest at a rate of 9.0% during the forecast period (2018-2023) owing to its sustainable benefits such as minimizing vessel trauma and reducing plaque burden. With 27% market share, stents contributed the highest revenue share in 2017. Increase in prevalence of CVDs coupled with benefits of stenting, such as rapid return to normalcy, improving blood flow, and brief hospitalization.

Request For Free Sample- https://www.kennethresearch.com/sample-request-10074102

End user segment insights:

Hospitals held the largest market share (48%) in 2017. Ambulatory surgical centers (ASCs) are expected to grow at a significant rate of 9.6% during the 2018-2023 period. With accelerated outpatient procedures, the prominence of ASCs is also swelling.

Regional insights:

The global interventional cardiology market can be divided into regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America led the global interventional cardiology market with a share of 38% in 2017. Asia-Pacific is expected to expand at a CAGR of 7.6% over 2018–2023. Wide adoption of stents is mostly magnifying the market share.

Companies Covered:

1. Medtronic PLC
2. Boston Scientific Corporation
3. Abbott Laboratories S.A.
4. C. R. Bard, Inc.
5. Johnson & Johnson Pvt. Ltd.
6. Edwards Lifesciences Corporation
7. Terumo Corporation
8. LivaNova, PLC.
9. B. Braun Melsungen AG
10. Teleflex Incorporated
11. MicroPort Medical Apparatus (Shanghai) Co. Ltd.

Buy Now- https://www.kennethresearch.com/report-purchase-id-10074102

Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: Global interventional cardiology market – overview

2.1. Global market overview - historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
2.8. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations

Read More- https://www.kennethresearch.com/report-details/global-interventional-cardiology-market-2018-2023/10074102

About Us

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

1412 Broadway,
21st Floor Suite MA111,
New York, NY 10018

Name:David
Email:sales@kennethresearch.com
Phone: +1 313 462 0609

This release was published on openPR.